Dr. Steven Beldner, MD

Dr. Beldner practices at Manhattan Eye Ear and Throat Hospital in New York, New York.

Dr. Beldner's NPI, 1740396019, was assigned on August 21, 2006. Dr. Beldner graduated from Rutgers New Jersey Medical School in 1991. Dr. Beldner holds New York license 194383.

Dr. Beldner's primary practice is Manhattan Eye Ear and Throat Hospital, at 210 E 64th St, New York, NY 10065 in New York County. The practice phone is (212) 434-4355.

Dr. Beldner's primary practice is Manhattan Eye Ear and Throat Hospital in New York, New York. Dr. Beldner is also affiliated with Hospital for Special Surgery. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Beldner to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beldner practices, 4 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Beldner's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Beldner is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Beldner's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists arm, wrist, hand fracture and dislocation, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, joint cyst and minor injury to a limb among the conditions Dr. Beldner treats.

CMS data shows 3,113 Medicare services from Dr. Beldner across 24 procedure codes in 2024, for 697 Medicare patients. Medicare paid $221,678 for them. Every service was in an office.

CMS counts 697 Medicare patients who saw Dr. Beldner in 2024. The largest group is 65 to 74, with 341 patients. 75% of them have high cholesterol, and 68% have arthritis. 4% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beldner's median patient age at 59, with 52% women.

In 2024, Dr. Beldner wrote 19 Medicare Part D claims for 16 patients. 89% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Beldner for performance year 2024, reported through an alternative payment model (APM). Dr. Beldner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beldner as offering telehealth. CMS counts 38 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Beldner, more than 80% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Beldner, published from 2012 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Joint Instability, Wrist Joint and Plastic Surgery Procedures. Dr. Beldner has published most often in Hand Clin. Dr. Beldner's most frequent co-authors are Daniel B. Polatsch, MD, Remy V. Rabinovich, MD and Charles P. Melone, MD.

CMS Open Payments shows 31 general payments to Dr. Beldner from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Arthrex, Inc. paid the most, $964.

Dmand AI lists 5 awards for Dr. Beldner, most recently New York Magazine: Top Doctors in 2014.

Dr. Beldner graduated from Rutgers New Jersey Medical School in 1991.

Dr. Beldner is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.